Analysts See $-0.01 EPS for Pharma-Bio Serv, Inc. (PBSV) on June, 13

May 17, 2018 - By Elizabeth Bryant

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) Corporate Logo

On June, 13 Pharma-Bio Serv, Inc. (OTCMKTS:PBSV)’s earnings report is expected by WallStreet, RTT reports. Analysts predict $-0.01 EPS. That’s $0.00 or 0.00 % from 2017’s earnings of $-0.01. $0.6 was the last price.Since May 17, 2017 it’s 0.00% down thus . PBSV underperformed the S&P500 by 11.55%.

Pharma-Bio Serv, Inc., a compliance and technology transfer services consulting company, provides compliance consulting services to the pharmaceutical, biotechnology, medical device, and chemical manufacturing companies in Puerto Rico, the United States, Europe, and Brazil.The firm is worth $13.84 million. The companyÂ’s technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support.Last it reported negative earnings. It also provides microbiological testing services and chemical testing services through its laboratory; and technical trainings/seminars.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: